Delphia (USA)’s NOV NOV Stock Holding History

Delphia (USA)’s Portfolio NOV Stock Details NOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,137	Closed	-$178K	–	372
2021 Q4	$178K	Buy	+13,137	New	+$180K	0.19%	229

Other funds holding NOV

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Delphia (USA)'s NOV Position: Q1 2022 in Review

Delphia (USA) sold out of NOV (NOV) in Q1 2022, closing a stake of 13,137 shares — an estimated $178K sold.

Delphia (USA) first reported a position in NOV in Q4 2021 and held it in 1 quarter. The position peaked at $178K in Q4 2021. 350 funds tracked by Wall St. Rank hold NOV as of Q1 2022.

Delphia (USA) reported no remaining NOV position as of Q1 2022 after selling out during the quarter.
Delphia (USA) sold 13,137 NOV shares in Q1 2022, an estimated $178K.
Delphia (USA) first reported a position in NOV in Q4 2021 and held it in 1 quarter.
Delphia (USA)'s NOV position peaked at $178K in Q4 2021.
350 funds tracked by Wall St. Rank held NOV as of Q1 2022.

Based on Delphia (USA)'s 13F filing for Q1 2022, filed 16 May 2022.